Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.625 USD | -0.96% | -6.67% | +72.51% |
May. 03 | Wedbush Adjusts Geron's Price Target to $7 From $6, Keeps Outperform Rating | MT |
May. 02 | Geron Shares Decline After Q1 Loss Widens | MT |
Business Summary
Number of employees: 141
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic Products for Oncology
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -60.23% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -60.23% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Scarlett
CEO | Chief Executive Officer | 73 | 11-09-28 |
Director of Finance/CFO | 57 | 23-09-24 | |
Faye Feller
CTO | Chief Tech/Sci/R&D Officer | 42 | 18-12-31 |
Andrew Grethlein
COO | Chief Operating Officer | 59 | 12-09-16 |
Aron Feingold
IRC | Investor Relations Contact | - | 22-02-28 |
Shannon Odam
HRO | Human Resources Officer | - | 19-06-19 |
Edward E. Koval
PRN | Corporate Officer/Principal | 62 | 21-11-30 |
Anil Kapur
PRN | Corporate Officer/Principal | 54 | 19-12-02 |
Scott Samuels
LAW | General Counsel | 54 | - |
Corporate Officer/Principal | 59 | 98-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
V. Lawlis
BRD | Director/Board Member | 72 | 12-03-14 |
John Scarlett
CEO | Chief Executive Officer | 73 | 11-09-28 |
Susan Molineaux
BRD | Director/Board Member | 70 | 12-09-27 |
Gaurav Aggarwal
BRD | Director/Board Member | 51 | Nov. 27 |
John McDonald
BRD | Director/Board Member | 63 | 22-09-06 |
Robert Spiegel
BRD | Director/Board Member | 73 | 10-05-18 |
Director/Board Member | 59 | 19-03-25 | |
Dawn Bir
BRD | Director/Board Member | 53 | 19-03-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 593,132,540 | 592,616,296 ( 99.91 %) | 0 | 99.91 % |
Company contact information
Geron Corp.
919 East Hillsdale Boulevard Suite 250
94404, Foster City
+650 473 7700
http://www.geron.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+72.51% | 2.17B | |
+10.63% | 115B | |
+12.26% | 106B | |
-5.59% | 24.69B | |
-1.60% | 21.97B | |
-5.24% | 19.27B | |
-11.04% | 17.56B | |
-39.36% | 17.32B | |
+5.91% | 14.03B | |
+33.49% | 12.13B |
- Stock Market
- Equities
- GERN Stock
- Company Geron Corporation